TAYEBEH KAZEMI

Prof. Dr. TAYEBEH KAZEMI


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2020 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
SHSeyed Basir Hashemi
Seyed Basir Hashemi
HBHaleh Bozorgi
Haleh Bozorgi
TKTAYEBEH KAZEMI
TAYEBEH KAZEMI
ABAmir Hossein Babaei
Amir Hossein Babaei
Introduction: Cochlear implants (CI) is considered a safe procedure with overall complication rate of 12.5% amongst adult and pediatric population. Cerebrospinal fluid (CSF) gusher is regarded as a common CI intraoperative complication. Objective: In this study, we determined the association between probable associated factors and occurrence of intraoperative CSF gusher. Method: In a retrospective survey, 394 patients with severe to profound sensorineural hearing loss who underwent primary cochlear implantation surgery were evaluated. Patients with incomplete electronic or manual file and those with revision, explantation or reimplantation surgery were excluded. Result: There hundred and ninety-four CI patients with a mean age of 8.74 ± 12.21 years were reviewed 49.62% of them were female. CSF gusher developed in 22 patients (5.58%). Patients with CSF gusher had more structural abnormalities in their CT scans’ report. The prevalence of Mondini dysplasia and common cavity malformation were the most common abnormal reports amongst those with intraoperative CSF gusher. Conclusion: In conclusion, cochlea structural abnormalities affect the incidence of CSF gusher in CI recipients. Common cavity malformation and Mondini dysplasia significantly increase the incidence of latter complication. We insist on more precise pre-operative imaging of those with abnormal cochlea structures to provide the needed management.

1 December 2010 in Acta Cytologica
Verified
Journal Article
Closed access
BKBijan Khademi
Bijan Khademi
TKTAYEBEH KAZEMI
TAYEBEH KAZEMI
ABAkbar Bayat
Akbar Bayat
HBHajar Bahranifard
Hajar Bahranifard
YDYahya Daneshbod
Yahya Daneshbod
MMMohammad Mohammadianpanah
Mohammad Mohammadianpanah
To describe the clinical and cytopathologic findings in 15 cases of salivary gland myoepithelial neoplasms and to assess the value of fine needle aspiration in the diagnosis of these tumors. Between 2000 and 2007, 15 consecutive patients were diagnosed with benign and malignant myoepithelioma of the head and neck region. A literature review of PubMed using the search terms myoepithelioma, myoepithelial carcinoma and salivary gland was performed. There were 8 men and 7 women. The age at presentation was 12-79 years (mean, 44.5). Parotid gland consisted of 73% of all primary sites. There were 10 benign and 5 malignant myoepitheliomas. In the benign group, only in 1 case did fine needle aspiration (FNA) revealed benign spindle cell variant, and in others, FNA diagnosis was mixed tumor. Similarly, in the malignant group, FNA diagnosis was malignant in only I case. The predominant cell morphology in the benign group was plasmacytoid cells, followed by a spindle and clear cell population. The cell morphology in the malignant lesions was epithelioid cell, clear cell and spindle cell. Scant fibrillary myxoid material was observed in both benign and malignant specimens. In the literature review and by analyzing the pooled data from 24 major reported series including 601 patients, the mean age at diagnosis was 51 years, and the mean male/female ratio was 1/.01. In addition, 39% of all tumors were malignant, and parotid gland consisted of 45% of all primary sites. According to the findings of the present study and review of the literature, the cytologic criteria for preoperative diagnosis ofsalivary gland myoepithelial neoplasms remain unsatisfactory and need to be clarified.

7 January 2022 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
TKTAYEBEH KAZEMI
TAYEBEH KAZEMI
SHSeyed Basir Hashemi
Seyed Basir Hashemi
NKNajmeh Keshavarz
Najmeh Keshavarz
LMLeila Monshizadeh
Leila Monshizadeh
RKReza Kaboodkhani
Reza Kaboodkhani
ABAmir Hossein Babaei
Amir Hossein Babaei

29 June 2020 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
MFMohammad Faramarzi
Mohammad Faramarzi
MSMahmood Shishegar
Mahmood Shishegar
TKTAYEBEH KAZEMI
TAYEBEH KAZEMI
HSHamid Tavakolpour Saleh
Hamid Tavakolpour Saleh
SRSareh Roosta
Sareh Roosta

4 October 2021 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
MFMohammad Faramarzi
Mohammad Faramarzi
PPPegah Pedramfard
Pegah Pedramfard
SRSareh Roosta
Sareh Roosta
TKTAYEBEH KAZEMI
TAYEBEH KAZEMI
HAHanie Aboughadare
Hanie Aboughadare
Objective: We carried out this research to assess and compare post‐stapedotomy hearing results of Matrix titanium prosthesis with a Teflon piston prosthesis, specifically the fluoroplastic (Teflon) Causse loop piston prosthesis in patients who suffered from otosclerosis.Methodology: In this retrospective study, Causse loop piston prosthesis was used in 81 ears, and the Matrix prosthesis was applied in 44 ears. For pairwise matching with Matrix prosthesis, 44 out of 81 Causse loop piston‐treated ears were selected based on preoperative audiometric data. Then, postoperative audiometric results of these two groups were compared. The main outcomes were pure tone audiometric results and air‐bone gap (ABG) closure before and after the surgery. Incidence of postoperative sensorineural hearing loss was also evaluated and compared between the two groups.Results: The results revealed no significant difference in improvement of speech reception threshold, mean air conduction, bone conduction gain, ABG closure, and incidence of postoperative sensorineural hearing loss at the frequencies of 0.5‐4 kHz between the two groups. However, performance of Matrix prosthesis was better in ABG closure at a frequency of 250 Hz.Conclusion: Herein, similar postoperative improvement was achieved at the frequencies of 0.5‐4 kHz; nevertheless, Matrix provided better ABG closure at frequency of 250 Hz in short term.Level of Evidence: 4

27 September 2021 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
MFMohammad Faramarzi
Mohammad Faramarzi
TKTAYEBEH KAZEMI
TAYEBEH KAZEMI
MSMahmoud Shishegar
Mahmoud Shishegar
OZOmid Zargerani
Omid Zargerani
AFAli Faramarzi
Ali Faramarzi
ABAmir Hossein Babaei
Amir Hossein Babaei
Objectives The aim of this study was to evaluate whether intraoperative ciprofloxacin-soaked gelfoam is safe in tympanoplasty or not. Method In this randomized, double-blind controlled clinical study, we included 100 patients between 18 and 60 years old, having perforation ≥50% of the tympanic membrane and dry ear for at least 2 months who were a candidate for underlay tympanoplasty via postauricular approach. We used ciprofloxacin soaked gelfoam in the case group and betamethasone soaked gelfoam in the control group for packing the middle ear cavity and external auditory canal during their operation. The graft success rate and tympanogram after 6 months follow-up period was considered as the primary outcome. Also, we evaluated the postoperative hearing results 6 months after the surgery as the secondary outcomes. Results Postoperative microscopic otoscopy showed a graft success rate of 100% (44/44) and 97.7% (42/43) in the case and control groups, respectively. The level of improvement between the two groups was not significant for air-bone gap (ciprofloxacin: 9.01 ± 7.89 dB, betamethasone 5.31 ± 10.53 dB, P = .160), and speech reception thresholds (SRT; ciprofloxacin: 10.23 ± 8.62 dB, betamethasone 7.33 ± 12.60 dB, P = .260). 93.2% of all the ears in the case group and 81.4% of those in the control group achieved postoperative air-bone gap within 20 dB, but the difference between them was not significant (P = .118). Conclusions We found that the application of ciprofloxacin impregnated gelfoam in the middle ear, and the external auditory canal had no adverse effect on the graft success rate in tympanoplasty. Levels of evidence 1b.